Showing 581 - 600 results of 2,017 for search '(( significant decrease decrease ) OR ( significant declines decrease ))~', query time: 0.47s Refine Results
  1. 581
  2. 582
  3. 583
  4. 584
  5. 585
  6. 586
  7. 587
  8. 588

    Johnsen testicular biopsy score. by Halime Tozak Yıldız (21238185)

    Published 2025
    “…<div><p>Purpose</p><p>Cisplatin is a commonly used chemotherapy agent effective against various cancers, however it induces significant gonadotoxicity and infertility due to its adverse effects on testicular function. …”
  9. 589

    Nanoparticle tracking analysis. by Halime Tozak Yıldız (21238185)

    Published 2025
    “…<div><p>Purpose</p><p>Cisplatin is a commonly used chemotherapy agent effective against various cancers, however it induces significant gonadotoxicity and infertility due to its adverse effects on testicular function. …”
  10. 590

    Sperm count and motility. by Halime Tozak Yıldız (21238185)

    Published 2025
    “…<div><p>Purpose</p><p>Cisplatin is a commonly used chemotherapy agent effective against various cancers, however it induces significant gonadotoxicity and infertility due to its adverse effects on testicular function. …”
  11. 591

    Primer sequences used for RT-PCR. by Jingjing Chen (293564)

    Published 2025
    “…Notably, SIRT1 levels decrease with age in both mice and during cellular senescence, highlighting its significance in anti-aging processes. …”
  12. 592
  13. 593

    Study flow chart. by Raymond Atwine (18574812)

    Published 2025
    “…The risk of ADCs increased from stage 2 (OR: 0.46, p-value: 0.03; 95% CI: 0.23–0.91) to stage 3 (OR: 1.13; p-value: 0.66; 95% CI: 0.65–1.97) but this was not statistically significant. The risk of ADCs decreased with increasing ART duration (<i>P</i> value < 0.05).…”
  14. 594

    Bar graph showing proportion of NADCs. by Raymond Atwine (18574812)

    Published 2025
    “…The risk of ADCs increased from stage 2 (OR: 0.46, p-value: 0.03; 95% CI: 0.23–0.91) to stage 3 (OR: 1.13; p-value: 0.66; 95% CI: 0.65–1.97) but this was not statistically significant. The risk of ADCs decreased with increasing ART duration (<i>P</i> value < 0.05).…”
  15. 595

    Baseline characteristics of study participants. by Raymond Atwine (18574812)

    Published 2025
    “…The risk of ADCs increased from stage 2 (OR: 0.46, p-value: 0.03; 95% CI: 0.23–0.91) to stage 3 (OR: 1.13; p-value: 0.66; 95% CI: 0.65–1.97) but this was not statistically significant. The risk of ADCs decreased with increasing ART duration (<i>P</i> value < 0.05).…”
  16. 596

    The sequences of si-RNAs used in this study. by Changji Li (4806930)

    Published 2024
    “…Our study observed a significant increase in CRNN expression in cSCC samples compared to healthy skin. …”
  17. 597
  18. 598
  19. 599
  20. 600